Form 483

Spes Medica srl Form 483, 2012-10-04

FDA issued a Form 483 to Spes Medica srl on 2012-10-04 with 7 public-safe observations.

483· Form 483 issued7 observations

Spes Medica srl · Battipaglia, Italy · Issued October 4, 2012

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

4 Oct 2012
21 CFR 820.22

Quality audits - auditor independence

Cited by Melissa I Michurski

4 Oct 2012
21 CFR 820.30(i)

Design changes - Lack of or Inadequate Procedures

Cited by Melissa I Michurski

4 Oct 2012
21 CFR 820.70(c)

Environmental control Lack of or inadequate procedures

Cited by Melissa I Michurski

4 Oct 2012
21 CFR 820.70(g)(1)

Maintenance schedule, Lack of or inadequate schedule

Cited by Melissa I Michurski

4 Oct 2012
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Melissa I Michurski

Inspected site

SMSpes Medica srlBattipaglia, Italy

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.181Cited across public-safe Form 483 observations1x
21 CFR 820.184Cited across public-safe Form 483 observations1x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.30(i)Cited across public-safe Form 483 observations1x
21 CFR 820.70(c)Cited across public-safe Form 483 observations1x
21 CFR 820.70(g)(1)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 7 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere